Skip to main content

Table 2 In vitro antifungal activity and MIC of compounds 4 and 5 using agar well diffusion method

From: Synthesis of some novel 4-arylidene pyrazoles as potential antimicrobial agents

Compound a Diameter of zone of inhibition in mm (MIC) b
  Candida albicans Saccharomyces cerevisiae
4a 12 ± 0.43 (400) 28 ± 0.15 (0.04)
4b 12 ± 0.56 (400) 16 ± 0.38 (40)
4c 12 ± 0.54 (400) 16 ± 0.40 (40)
4d 14 ± 0.14 (400) 20 ± 0.45 (4.0)
4e 12 ± 0.45 (400) 18 ± 0.16 (40)
4f 12 ± 0.32 (400) 16 ± 0.27 (40)
4g 16 ± 0.27 (40) 18 ± 0.48 (40)
5a 12 ± 0.32 (400) 16 ± 0.00 (40)
5b 12 ± 0.33 (400) 28 ± 0.28 (0.04)
5c - 16 ± 0.00 (40)
5d 12 ± 0.23 (400) 18 ± 0.18 (40)
5e 13 ± 0.37 (400) 22 ± 0.44 (4.0)
5f - 16 ± 0.30 (40)
5g 12 ± 0.43 (400) 20 ± 0.10 (4.0)
Fluconazole 16 ± 0.45 (40) 24 ± 0.50 (40)
  1. MIC (μg/mL), minimum inhibitory concentration. Hyphen denotes no activity. aThe concentration is 4.0 mg/mL. bThe values, including the diameter of the well (8 mm), are means of the three replicates.